John Valliant

John Valliant is the current CEO of Fusion Pharmaceuticals. John previously worked at the Centre for Probe Development and Commercialization and McMaster University.

John Valliant has a Ph.D. in Chemistry from McMaster University.

Some direct reports include Christopher Leamon - Chief Scientific Officer, Eric S. Hoffman - SVP, Business Development, and Mohit Rawat - President & Chief Business Officer.